ethyl pyruvate has been researched along with Experimental Spinal Cord Ischemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albadawi, H; Cambria, RP; Crawford, RS; Fink, MP; Nguyen, BN; Oklu, R; Watkins, MT | 1 |
Chen, S; Ding, Q; Gou, X; Hou, L; Wang, Q; Xiong, L; Zhou, Y; Zhu, Z | 1 |
2 other study(ies) available for ethyl pyruvate and Experimental Spinal Cord Ischemia
Article | Year |
---|---|
Ethyl pyruvate modulates delayed paralysis following thoracic aortic ischemia reperfusion in mice.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Apoptosis; Apoptosis Regulatory Proteins; Constriction; Disease Models, Animal; Inflammation; Inflammation Mediators; Male; Mice, Inbred C57BL; Neuroprotective Agents; Paralysis; Pyruvates; Regional Blood Flow; Reperfusion Injury; Signal Transduction; Spinal Cord; Spinal Cord Ischemia; Time Factors | 2016 |
Ethyl pyruvate attenuates spinal cord ischemic injury with a wide therapeutic window through inhibiting high-mobility group box 1 release in rabbits.
Topics: Animals; Apoptosis; Blood Gas Analysis; Blood Glucose; Body Temperature; Coloring Agents; Enzyme-Linked Immunosorbent Assay; Hemodynamics; High Mobility Group Proteins; Hindlimb; In Situ Nick-End Labeling; Male; Pyruvates; Rabbits; Reperfusion Injury; Repressor Proteins; Spinal Cord Ischemia | 2009 |